Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Core Insights - Biodesix, Inc. will present at the TD Cowen 45th Annual Health Care Conference on March 5, 2025, with CEO Scott Hutton and CFO Robin Cowie participating in a fireside chat and hosting in-person investor meetings [1][2]. Company Overview - Biodesix is a leading diagnostic solutions company with five Medicare-covered tests for pulmonology patients, including the Nodify Lung® Nodule Risk Assessment and the IQLung™ test portfolio for lung cancer patients [3]. - The Nodify Lung® test helps evaluate the risk of malignancy in pulmonary nodules, aiding physicians in patient triage [3]. - The IQLung™ test portfolio supports treatment decisions across all stages of lung cancer and facilitates personalized treatment [3]. - Biodesix collaborates with top biopharmaceutical companies for biomarker discovery, diagnostic test development, and clinical trial support services [3].